Kasowitz Revives $100 Million Cardiovascular Stent Litigation Against Boston Scientific

Kasowitz Revives $100 Million Cardiovascular Stent Litigation Against Boston Scientific

On August 22, 2012, Kasowitz achieved a major victory for interventional cardiologist Dr. G. David Jang in his litigation against Boston Scientific relating to Dr. Jang’s patented cardiovascular stent designs.  Dr. Jang asserts that Boston Scientific implemented his designs in its stent products, but failed to pay him $100 million in compensation that it was obligated to pay.  Dr. Jang brought suit in federal court in the Central District of California, but his claims were derailed in 2007 by an adverse claim construction ruling from the district court and a stipulated judgment followed.  In 2011, after an initial appeal was ineffective, Kasowitz replaced prior counsel and handled a second appeal targeting the adverse claim construction ruling.  In its August 2012 ruling, the Federal Circuit reversed the district court’s claim construction, vacated the judgment, and remanded the action to the Central District of California for further proceedings.  The Kasowitz team now represents Dr. Jang in the soon-to-be reinstituted district court litigation.  Kasowitz partner Jed I. Bergman represents Dr. Jang in this matter.